https://biotechmorning.com/news/jnj-stelara-revenue-plummets-wall-street-cheers Biotech Morning en 2026-07-13T14:27:31.475Z J&J Just Lost 43% of Stelara Revenue. Why Is Wall Street Cheering? https://biotechmorning.com/news/ai-picks-cancer-patients-who-survive Biotech Morning en 2026-07-13T14:26:39.105Z The AI That Picks Which Cancer Patients Will Actually Survive https://biotechmorning.com/news/crispr-first-cure-casgevy-unexpected-problem Biotech Morning en 2026-07-13T14:25:48.214Z CRISPR's First Cure Has a Problem Nobody Saw Coming https://biotechmorning.com/news/gene-therapy-sickle-cell-toddlers-fda-approval Biotech Morning en 2026-07-13T14:24:56.429Z The 2-Year-Old Who Could Be Cured Before Kindergarten https://biotechmorning.com/news/fda-overrules-experts-moderna-flu-vaccine Biotech Morning en 2026-07-13T14:24:07.227Z The FDA Just Overruled Its Own Experts on Moderna's Flu Shot https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework Biotech Morning en 2026-07-13T14:23:12.159Z The FDA Just Made It Easier to Build a Drug for One Patient https://biotechmorning.com/news/car-t-therapy-intercept-multiple-myeloma-before-it-starts Biotech Morning en 2026-07-13T14:22:21.643Z What If You Could Kill Cancer Before It Even Starts? https://biotechmorning.com/news/bladder-cancer-chemo-monopoly-broken-keytruda-padcev Biotech Morning en 2026-07-13T14:21:32.347Z Bladder Cancer's Chemo Monopoly Just Got Broken https://biotechmorning.com/news/astrazeneca-cspc-extrahepatic-sirna-deal Biotech Morning en 2026-07-12T14:22:16.679Z AstraZeneca's $1.77 Billion Bet on the Organ Nobody Can Target https://biotechmorning.com/news/bundibugyo-ebola-american-infected-no-vaccine Biotech Morning en 2026-07-12T14:21:21.393Z The Ebola Strain Nobody Has a Vaccine For Just Infected an American https://biotechmorning.com/news/arpa-h-160-million-custom-gene-editing-thrive Biotech Morning en 2026-07-12T14:20:26.190Z Uncle Sam Just Bet $160 Million That Gene Editing Can Go Custom https://biotechmorning.com/news/vaccine-skeptic-nominee-emergency-health-role Biotech Morning en 2026-07-12T14:19:35.058Z The Man Who'd Rather Die Than Vaccinate His Kids Might Run U.S. Emergency Health https://biotechmorning.com/news/fda-slams-door-cheap-ozempic-knockoffs Biotech Morning en 2026-07-12T14:18:40.934Z The FDA Just Slammed the Door on Cheap Ozempic Knockoffs https://biotechmorning.com/news/lilly-zepbound-cheaper-single-dose-vials Biotech Morning en 2026-07-12T14:17:51.708Z Lilly Just Turned Zepbound Into a Costco-Style Bargain https://biotechmorning.com/news/novo-nordisk-wegovy-subscription-pricing Biotech Morning en 2026-07-12T14:16:55.615Z Novo Nordisk Wants You to Subscribe to Wegovy Like It's Netflix https://biotechmorning.com/news/ipsen-memo-therapeutics-bk-virus-deal Biotech Morning en 2026-07-12T14:15:56.170Z The Virus No One Has a Drug For (and the €700M Bet to Change That) https://biotechmorning.com/news/eplontersen-attr-cm-phase-3-failure Biotech Morning en 2026-07-12T14:14:55.389Z The Drug That Worked Perfectly and Still Failed https://biotechmorning.com/news/relacorilant-cortisol-ovarian-cancer-approval Biotech Morning en 2026-07-12T14:14:08.935Z The Drug That Turns Your Own Stress Hormones Against Cancer